• Mashup Score: 0

    Despite remarkable progress in asthma management and targeted therapies, challenges persist in effectively addressing difficult-to-treat asthma patients. Addressing modifiable factors, such as nonadherence, inadequate inhaler technique, and poorly controlled comorbidities such as those that are asthma mimickers, are necessary for adequate asthma control.1 Sanchis et al2 showed that adherence to asthma inhalers falls below that for medications for other chronic conditions and that correct inhaler use technique has remained unacceptably low over the last 40 years, all of which are a call to action in this space.

    Tweet Tweets with this article
    • In Current Issue (FREE)! Improving Difficult-to- #Treat #Asthma With #Digital #Inhaler #Adherence #Technologies: Are We There Yet? https://t.co/UfFapAV63w

  • Mashup Score: 7

    Baylor University Medical Center, Dallas, TX; Imperial College, London, UK Baylor Scott and White Research Institute, Dallas, TX; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS Boehringer Ingelheim Pharma GmbH and Co KG, Biberach, Germany Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg,

    Tweet Tweets with this article
    • Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in #HF. Try to maintain long term #adherence to Tx #ESCCongress https://t.co/1OG4aUaqks

  • Mashup Score: 5

    Increased use of orally administered agents in multiple myeloma offers added convenience for patients [1]; however, possible nonadherence is a concern. Retrospective studies have demonstrated that average adherence to oral myeloma therapy ranges from 58 to 90% [2–6]. Measuring adherence is challenging, which may explain the varying estimates.

    Tweet Tweets with this article
    • RT @JGeriOnc: A pilot study of adherence to lenalidomide among older patients with multiple myeloma https://t.co/TRNFUDPalW @MelissaLoh21 @…

    • A pilot study of adherence to lenalidomide among older patients with multiple myeloma https://t.co/TRNFUDPalW @MelissaLoh21 @HiraSMian @tanyawildes @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #MedicationPossessionRatio #Adherence https://t.co/iZ1hUrmQw1